<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114377">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01998867</url>
  </required_header>
  <id_info>
    <org_study_id>R2013-1003</org_study_id>
    <nct_id>NCT01998867</nct_id>
  </id_info>
  <brief_title>Fasting Predictors of OGTT and MMTT Response</brief_title>
  <official_title>Identification of Fasting Biomarkers That Predict Responses to the Oral Glucose Tolerance Test (OGTT) and Mixed Meal Tolerance Test (MMTT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Health Diagnostic Laboratory, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Health Diagnostic Laboratory, Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. To develop a database containing matched information from dynamic tests of postprandial
           glycemic control (OGTT or MMTT), results of a broad panel of fasting biomarkers, and
           clinical information related to diabetes risk obtain through subject interview.

        2. To use the database to identify fasting biomarkers and associated algorithms to best
           predict parameters derived from dynamic tests (OGTT or MMTT) such as Insulin Glucose
           Tolerance (IGT), impaired first phase insulin response, etc., controlling for clinical
           information such as current medication use.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Identify fasting biomarkers and associated algorithms to predict parameters</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess relations between baseline factors and patterns of change over time due to feeding treatments.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Prediabetes</condition>
  <condition>Hypertension</condition>
  <condition>Obesity</condition>
  <condition>Cardiovascular Disease</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood and serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Representative of the ethnic population of Richmond, VA
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Weight &gt;95

        Exclusion Criteria:

          -  Prior diagnosis of Diabetes
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Szilard Voros, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Health Diagnostic Laboratory, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephen Varvel, PhD</last_name>
    <phone>804-343-2718</phone>
    <phone_ext>2231</phone_ext>
    <email>svarvel@hdlabinc.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Monique Alston, LPN</last_name>
    <phone>804-343-2718</phone>
    <phone_ext>2210</phone_ext>
    <email>malston@hdlabinc.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Health Diagnostic Laboratory, Inc.</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monique Alston, LPN</last_name>
      <phone>804-343-2718</phone>
      <phone_ext>2210</phone_ext>
      <email>malston@hdlabinc.com</email>
    </contact>
    <contact_backup>
      <last_name>Stephen Varvel, PhD</last_name>
      <phone>804-836-4439</phone>
      <email>svarvel@hdlabinc.com</email>
    </contact_backup>
    <investigator>
      <last_name>Szilard Voros, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 1;127(1):143-52. doi: 10.1161/CIR.0b013e318282ab8f. Review.</citation>
    <PMID>23283859</PMID>
  </reference>
  <reference>
    <citation>Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 3;125(1):188-97. doi: 10.1161/CIR.0b013e3182456d46. Erratum in: Circulation. 2012 Jun 5;125(22):e1001.</citation>
    <PMID>22215894</PMID>
  </reference>
  <reference>
    <citation>DeFronzo RA, Abdul-Ghani M. Type 2 diabetes can be prevented with early pharmacological intervention. Diabetes Care. 2011 May;34 Suppl 2:S202-9. doi: 10.2337/dc11-s221. Review.</citation>
    <PMID>21525456</PMID>
  </reference>
  <reference>
    <citation>Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B; American Diabetes Association. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007 Mar;30(3):753-9. Review.</citation>
    <PMID>17327355</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 25, 2013</lastchanged_date>
  <firstreceived_date>November 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
